Join JPI UE
Please click here for the frequently asked questions we collected.
If you have an additional questions you are welcome to mail us at firstname.lastname@example.org
The dramatic spread of COVID-19 has disrupted lives, livelihoods, communities and businesses worldwide. Cities have been the hardest hit by the crisis. Indeed, the COVID-19 pandemic has further confirmed that most of our societal challenges are intrinsically urban. Compact cities have been struggling to ensure physical distancing while trying to reorganise health-care and school facilities, rearrange urban mobility systems and support vulnerable social groups.
However, cities are also key players in responding to the COVID-19 crisis and other societal challenges. Cities are the hubs of global innovation: they often team up with universities, civil society organisations, start-ups, Small and Medium-sized Enterprises (SMEs) and other private companies to have access to innovative technologies and solutions. Science, research and innovation are helping European cities of different size to find innovative ways to weave together every strand of their community, so that every resident has a fair shot at opportunity and prosperity.
In this respect, supporting diversity and inclusion (D&I) becomes crucial to ensure the ‘right to the city’ for all, fighting discrimination and biases based on age, sex, gender identity, sexual orientation, disability, race, ethnicity, language, geographical location, migrant status, or any other reason.
Join this webinar organised by the Directorate General for Research & Innovation (DG R&I) and the Executive Agency for Small and Medium-sized Enterprises (EASME) of the European Commission in cooperation with the World Economic Forum Covid Action Platform and its initiative Hour of Pride on 7 July to learn more about:
7 July 2020 – Zoom Webinar.
Please register at: https://zoom.us/webinar/register/WN_jXyKj8kLTPmkCrNGfEpGGg
15:00 – 16:30 CEST
This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 857160.